Cover 2 Resources
Cover 2 Resources
Ep. 218 - Pharmaceutical Company Adopts “Glengarry Glen Ross“ Sales Culture of Purdue Pharma
Ep. 218 - Pharmaceutical Company Adopts “Glengarry Glen Ross“ Sales Culture of Purdue Pharma
Ep. 218 - Pharmaceutical Company Adopts “Glengarry Glen Ross“ Sales Culture of Purdue Pharma
Thursday 6th December 2018
Greg McNeil and Evan Hughes uncover how INSYS Therapeutics' deceptive sales tactics fueled the opioid crisis. Listen now on Cover2 Resources.
29 minutes
Informative
Thought-provoking
Eye-opening
Educational
Supportive
About this podcast
Overview:
Categories:
Innovative Treatments & Recovery Paths
Family Recovery from Addiction
Sobriety Toolkit
Body & Mind
Navigating Intimate Relationships
Links:
Visit site
Episodes:
284 (View all)
Do you want to link to this podcast?
Get the buttons here!Pharmaceutical Greed: Inside the Deceptive Sales Tactics Fueling the Opioid Crisis
One lesson that I've drawn from reporting on INSYS is to educate yourself and be aware of the practices of pharmaceutical companies, the way that drugs are sold, and to be aware that doctors are fallible and human, just like anybody else.
Imagine being prescribed a medication that could lead to addiction, all because of shady sales tactics. In this gripping episode of Cover2 Resources, host Greg McNeil sits down with Evan Hughes, an acclaimed author and journalist for top publications like GQ and The New York Times. They dive into the murky waters of pharmaceutical sales practices, focusing on INSYS Therapeutics and their controversial marketing strategies for their fentanyl product, Subsys.
Hughes shares eye-opening details from his New York Times article, 'The Pain Hustlers', revealing how INSYS paid millions to doctors through their 'Speaker Program' to push this highly addictive drug, even for conditions it wasn’t originally intended to treat. The conversation also touches on the legal loopholes that allow such practices to continue and the devastating impact on patients and communities. With a trial looming, Hughes discusses what the future might hold for pharmaceutical companies employing these tactics.
This episode is a must-listen for anyone wanting to understand the role of corporate greed in the opioid epidemic and the urgent need for public awareness and education. Tune in to learn how you can be part of the solution in combating this crisis.